Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'
- PMID: 32854077
- DOI: 10.1016/j.ejca.2020.07.014
Letter to the editor: Comments on 'A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation'
Comment on
-
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation.Eur J Cancer. 2020 May;131:68-75. doi: 10.1016/j.ejca.2020.02.016. Epub 2020 Apr 15. Eur J Cancer. 2020. PMID: 32305010
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical